Exploring Mirion Technologies, Inc. (MIR) Investor Profile: Who’s Buying and Why?

Exploring Mirion Technologies, Inc. (MIR) Investor Profile: Who’s Buying and Why?

US | Industrials | Industrial - Machinery | NYSE

Mirion Technologies, Inc. (MIR) Bundle

Get Full Bundle:
$12 $7
$12 $7
$12 $7
$12 $7
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

You've seen Mirion Technologies, Inc. (MIR) stock outperform, especially with the tailwinds in the nuclear power sector, and you're defintely wondering which big players are driving that momentum and why they're buying now. The simple answer is that institutional capital is doubling down on the nuclear renaissance story, which is translating directly into solid 2025 financials for this radiation detection specialist. Consider this: institutions already hold a massive 78.51% of the shares, and firms like Sumitomo Mitsui DS Asset Management Company Ltd. recently boosted their position by 169.4% in the second quarter alone. Why the conviction? The company just posted a Q3 2025 revenue of $223.1 million, up 7.9% year-over-year, and their Adjusted EPS of $0.12 comfortably beat the consensus. That's a real earnings beat, not just a whisper. Plus, with a full-year Adjusted EBITDA guidance of $223 million to $233 million and major wins like the $10 million small modular reactor (SMR) new build order, the smart money sees a clear path to growth. Are these large holders like BlackRock, Inc. just chasing a trend, or is this a deeper, long-term bet on critical infrastructure? Let's dive into the 13F filings to map out exactly who is buying and what their investment thesis is, because the numbers suggest this isn't a retail-driven rally.

Who Invests in Mirion Technologies, Inc. (MIR) and Why?

If you're looking at Mirion Technologies, Inc. (MIR), the first thing to understand is that this is an institutional-driven stock. The vast majority of the company is held by professional money managers, not individual retail investors, which tells you the investment thesis is tied to long-term, structural growth trends rather than short-term news cycles. Your decision-making needs to align with their big-picture view.

As of late 2025, institutional investors hold a dominant 78.51% of Mirion Technologies, Inc. shares. This is a high concentration, meaning major movements in the stock price are defintely driven by the buying and selling activity of large funds. The key players are the giants of the asset management world, including BlackRock, Inc., Vanguard Group Inc, T. Rowe Price Investment Management, Inc., and State Street Corp. These are often passive index funds and large-cap growth funds, but also active managers betting on the company's specific sector exposure.

Here's a quick breakdown of the investor composition, based on recent filings:

  • Institutional Investors: Own over 78% of the company. These are mutual funds, pension funds, and endowments.
  • Hedge Funds: A smaller but significant portion, often focused on the company's growth-by-acquisition strategy.
  • Retail Investors: Hold the remaining float, often following the lead of the institutional narrative.

Investment Motivations: Betting on Nuclear and Defense Tailwinds

The core of the investment thesis for Mirion Technologies, Inc. is its critical, non-cyclical position in the nuclear, defense, and medical markets. Investors aren't buying a commodity; they're buying a global leader in radiation detection and monitoring solutions. The company's Q3 2025 results underscore this, reporting revenue of $223.1 million and a jump to a GAAP net income of $3.1 million from a net loss in the prior year period.

The biggest near-term opportunity driving this interest is the nuclear power end-market. Mirion Technologies, Inc. is directly exposed to the global push for carbon-free energy and the modernization of existing nuclear fleets. The company saw a 44% surge in U.S. nuclear orders in 2025, reflecting robust activity in the small modular reactor (SMR) space. Plus, strategic acquisitions like Paragon Energy Solutions are expected to increase nuclear power-based revenue to approximately 45% of total revenue, solidifying its market position. This is a clear-cut, long-term growth story.

The company's full-year 2025 guidance reflects this confidence, projecting Adjusted EBITDA between $223 million and $233 million and Adjusted EPS between $0.48 and $0.52 per share. For a deeper dive into the company's long-term vision that underpins these numbers, you should review the Mission Statement, Vision, & Core Values of Mirion Technologies, Inc. (MIR).

Investment Strategies: Growth at a Premium

The typical strategy here is a clear growth-oriented approach, not a traditional value play. The company trades at a premium valuation, with a high P/E ratio of 269.09 as of late 2025. This tells you investors are willing to pay up for expected future earnings, essentially pricing in the next few years of growth.

The significant returns over the past few years-a 77.1% total shareholder return over the last 12 months and an impressive 338.7% over three years-have attracted momentum investors. They are buying into the narrative of a rapid business transformation and aggressive expansion strategy, particularly in the advanced nuclear sector. This is a long-term holding strategy focused on capitalizing on multi-year, large opportunity pipelines, such as the company's previously communicated $350 million pipeline.

Here's how the major institutional strategies map to Mirion Technologies, Inc.'s profile:

Strategy Investor Profile Mirion Technologies, Inc. Rationale
Long-Term Growth Mutual Funds, Pension Funds Exposure to structural, long-term trends in nuclear energy and defense; high 3-year return of 338.7%.
Momentum Investing Hedge Funds, Active Managers Strong recent share price performance (up 77.1% in 12 months) and consistent earnings beats, like the Q3 2025 Adjusted EPS of $0.12 beating the $0.099 consensus.
Growth-at-a-Reasonable-Price (GARP) Select Active Managers Focus on the company's ability to translate revenue growth (guided at 7.0% - 9.0% for FY 2025) into rising profit margins and adjusted free cash flow, which was raised to between $100 million and $115 million.

The current analyst consensus is a 'Buy,' with an average 1-year price target of $28.50, which suggests the market still sees upside despite the premium valuation. You need to monitor the execution of their acquisition strategy and the conversion of that large opportunity pipeline; that's the key to justifying the stock's current price.

Institutional Ownership and Major Shareholders of Mirion Technologies, Inc. (MIR)

The short answer is that institutional investors overwhelmingly own Mirion Technologies, Inc. (MIR), and their buying activity accelerated significantly throughout the 2025 fiscal year. This high level of institutional control-nearly all of the float-signals a strong validation of the company's strategy in radiation safety, science, and medicine.

As of late 2025, institutions hold approximately 94.6% of the common stock, controlling a total of over 242.6 million shares. This concentration means that the stock's price and long-term direction are defintely dictated by the conviction of a few major players. You need to watch their moves closely because they are the market.

Who Holds the Largest Stakes in Mirion Technologies, Inc.?

The investor profile is dominated by the world's largest asset managers, primarily those running index and large mutual funds. These top-tier firms are essentially staking their claim on Mirion Technologies, Inc.'s future revenue streams from its Medical and Nuclear & Safety segments. Here is the breakdown of the top three holders, based on their latest 2025 filings:

Institutional Investor Shares Held (as of Sep 30, 2025) Value (USD) % of Company
BlackRock, Inc. 36,430,491 $897.9 million 15.9%
The Vanguard Group, Inc. 30,418,327 $749.7 million 13.3%
T. Rowe Price Group, Inc. 21,126,665 $520.7 million 9.22%

Here's the quick math: the top two alone, BlackRock, Inc. and The Vanguard Group, Inc., account for over a quarter of the company's total ownership. When you see names like this, it often means a large portion of the shares are held passively through index funds, providing a bedrock of stability for the stock.

Recent Shifts: Institutional Accumulation is Strong

The most telling trend in 2025 has been the aggressive accumulation, which suggests a high level of confidence in the company's execution and market position. The overall institutional shares (long positions) increased by over 22% in the most recent quarter alone. This isn't just passive holding; it's active buying.

The largest institutions have been driving this change:

  • BlackRock, Inc. increased its stake by a massive 114% as of the September 30, 2025 filing.
  • The Vanguard Group, Inc. grew its position by 28% in the same period.
  • Sumitomo Mitsui DS Asset Management Company Ltd. lifted its holdings by 169.4% in the second quarter of 2025, acquiring an additional 148,619 shares.
  • CWM LLC boosted its position by 162.9% in Q2 2025, reaching a value of $364,000.

This accumulation validates the company's performance, especially after it beat quarterly estimates and issued a strong full-year 2025 guidance of $0.480 to $0.520 in Earnings Per Share (EPS). It tells you that the smart money is betting on the company's continued growth, which you can read more about in Mirion Technologies, Inc. (MIR): History, Ownership, Mission, How It Works & Makes Money.

Impact on Stock Price and Corporate Strategy

A high institutional ownership percentage, especially one that is growing rapidly, has two primary impacts for you as an investor or strategist. First, it provides a crucial floor for the stock price. When nearly all shares are held by large, sophisticated funds, the daily trading volume is lower, and the stock is less prone to wild swings based on retail sentiment. This creates price stability.

Second, and more importantly, these large shareholders exert significant influence on corporate governance and strategic direction. They expect management to deliver on the growth story that prompted their investment. Their accumulation serves as a loud vote of confidence in the company's focus on mission-critical sectors like nuclear energy and cancer care. If they start selling, however, the lack of a large retail base means the stock price could drop fast. So, while their buying is a green light, their selling is a serious risk.

Key Investors and Their Impact on Mirion Technologies, Inc. (MIR)

You want to know who is buying Mirion Technologies, Inc. (MIR) and why, and the short answer is that the stock is overwhelmingly owned by large, long-term institutions who are betting on the nuclear and medical tailwinds. Institutional investors hold approximately 78.51% of the company's shares, giving them a commanding voice in corporate governance and strategy.

This high level of institutional ownership means company decisions, like the recent strategic acquisitions, are made with the tacit approval of the world's largest asset managers. It's a vote of confidence, but it also means the stock price is highly sensitive to their collective buying or selling movements. For individual investors, following these giants is defintely a smart move.

The Big Three: Passive Giants and Their Staking Power

The investor profile of Mirion Technologies, Inc. (MIR) is dominated by the index fund and passive investing behemoths. These firms aren't typically activist-they are long-term holders whose sheer size gives them immense, quiet influence on everything from board composition to environmental, social, and governance (ESG) policies.

Here's the quick math on the top holders, based on the latest Q2 2025 filings and recent transactions, which shows their commitment to the stock:

Institutional Investor Shares Held (Approx.) Value (Approx. as of Q2 2025) Investment Style
Vanguard Group Inc. 30,418,327 $511.7 million Passive/Index
T. Rowe Price Investment Management, Inc. 20,957,520 $451.2 million Active/Growth
BlackRock, Inc. 17,012,641 $366.3 million Passive/Index

Vanguard Group Inc. is the largest shareholder, and their position is critical. The presence of BlackRock, Inc. and Vanguard Group Inc. signals that Mirion Technologies, Inc. (MIR) is a core component of major index funds, which means a steady, reliable demand for the stock over time. T. Rowe Price Investment Management, Inc. is the key active manager in the top three, suggesting a belief in the company's growth story beyond just its index inclusion.

Recent Moves: A Show of Confidence and Capital Structure Shifts

We've seen some very notable activity in the second half of 2025 that paints a clear picture of investor sentiment. The biggest headline was Vanguard Group Inc.'s massive acquisition of an additional 6,651,735 shares on September 30, 2025, which significantly increased their total holdings. That's a huge, concrete buy signal, showing conviction in the company's long-term strategy, which you can read more about in their Mission Statement, Vision, & Core Values of Mirion Technologies, Inc. (MIR).

Also, the company itself was active in the capital markets in September 2025, executing an upsized public offering of Class A Common Stock and a $325.0 million offering of 0.00% Convertible Senior Notes due 2031. This move dilutes existing shareholders slightly, but it raises capital to fund growth and strategic acquisitions, like the announced Paragon Energy Solutions deal, which is expected to double the Small Modular Reactor (SMR) revenue potential and expand the nuclear power portfolio to approximately 45% of total revenue.

Other funds are also making aggressive moves:

  • Sumitomo Mitsui DS Asset Management Company Ltd. lifted its position by a staggering 169.4% in Q2 2025.
  • CWM LLC boosted its holdings by 162.9% in the same quarter.
  • Connor Clark & Lunn Investment Management Ltd. purchased a new position of 102,225 shares, valued at approximately $2.20 million in Q2 2025.

This buying pressure is a direct response to the company's strong performance, including the updated FY 2025 guidance for Adjusted EBITDA of approximately $223 million - $233 million and Adjusted EPS of $0.48 - $0.52 per share. The market is clearly rewarding the company for its focus on the high-growth nuclear and medical segments.

Activist and Value Investor Influence: The Cooperman Factor

While the biggest holders are passive, you also have a significant presence from value-oriented investors like billionaire Leon G. Cooperman, whose Omega Advisors holds a substantial stake. As of Q2 2025, Mirion Technologies, Inc. (MIR) was a top five holding in his portfolio, representing a 5.39% allocation. Cooperman is known for his value-investing philosophy and his willingness to engage management when he sees a path to unlocking shareholder value.

His influence is less about day-to-day operations and more about holding management's feet to the fire on long-term value creation. When a respected, value-focused investor like Cooperman is a large owner and is increasing his stake, it signals that he believes the stock is still undervalued, despite the high P/E ratio, based on the future cash flow potential from the nuclear and medical markets. This is a powerful form of non-activist influence, pressuring management to deliver on their long-term targets, like achieving 30% Adjusted EBITDA margins by 2028.

The collective action here is clear: the smart money sees the long-term growth story in Mirion Technologies, Inc. (MIR)'s specialized markets and is positioning for it now. Finance: Track the next 13F filings for Vanguard and BlackRock by the end of Q4 2025.

Market Impact and Investor Sentiment

You're looking at Mirion Technologies, Inc. (MIR) because the stock has been moving, and you want to know if the big money is still buying. The short answer is yes, institutional investor sentiment is defintely bullish, driven by solid 2025 fiscal year results and strategic moves in the nuclear power sector.

Institutional investors-the large funds like BlackRock, Inc. and Vanguard Group Inc-own a significant majority of the company, holding approximately 78.51% of the stock as of late 2025. This high level of institutional ownership signals a strong belief in Mirion Technologies, Inc.'s long-term business model, particularly its dual focus on Medical and Technologies segments.

Here's the quick math on investor conviction: many funds, including Robeco Schweiz AG and Connor Clark & Lunn Investment Management Ltd., have recently been increasing their multi-million dollar stakes. This isn't just passive indexing; it's a marked increase in positioning, suggesting these sophisticated players see a clear path to value creation.

Recent Market Reactions to Ownership Shifts

The stock market has a nuanced reaction to major investor activity, especially when it involves financing growth. Mirion Technologies, Inc. shares, which had surged 44.1% year-to-date through November 2025, showed classic volatility when the company announced its capital plans.

When Mirion Technologies, Inc. unveiled the $585 million acquisition of Paragon Energy Solutions, followed by a $600 million capital raise (a public stock offering and convertible bonds) to fund it, the market reacted with a sharp, albeit temporary, pullback. Shares lost nearly 11% on the day the financing was announced in September 2025, as investors priced in the dilution risk from the new stock offering.

This is a common pattern: the market dislikes dilution, but it respects a clear, accretive growth strategy. The acquisition is expected to significantly augment the company's U.S. nuclear power presence, increasing nuclear power-based revenue to approximately 45% of total revenue. For a deeper dive into the company's core operations, you can check out Mirion Technologies, Inc. (MIR): History, Ownership, Mission, How It Works & Makes Money.

Analyst Perspectives and the Path Forward

Wall Street analysts are overwhelmingly positive on Mirion Technologies, Inc.'s future, largely because of the company's execution and its position in the growing nuclear and medical markets. The consensus rating from nine analysts is a 'Buy,' with two even assigning a 'Strong Buy' recommendation.

The average 1-year price target is currently $28.50, but some firms are even more optimistic. For example, Citigroup recently raised its price objective to $35.00, and JP Morgan set a target of $34.00, underscoring confidence in the company's trajectory.

What this estimate hides is the potential for further upside from the nuclear energy tailwind. The analysts' optimism is grounded in the company's solid financial performance, including a strong third quarter 2025 where Adjusted EPS of $0.12 beat the consensus estimate of $0.10.

The company's reaffirmed full-year 2025 guidance is a clear indicator of stability and growth, which is exactly what the institutional money is looking for:

  • Adjusted EPS Guidance: $0.48 to $0.52 per share.
  • Adjusted EBITDA Guidance: $223 million to $233 million.
  • Organic Revenue Growth: Projected at 4.5% to 6.0%.

The institutional buying is a bet on Mirion Technologies, Inc. capitalizing on momentum in the nuclear power end-market and successfully integrating its strategic acquisitions, pushing the stock toward the high end of the current price targets.

Metric (FY 2025 Data) Value/Range Significance
Institutional Ownership ~78.51% High conviction from large funds.
Analyst Consensus Rating Buy / Strong Buy Overwhelmingly positive Wall Street view.
Average 1-Year Price Target $28.50 Represents significant upside from current price.
FY2025 Adjusted EPS Guidance $0.48 - $0.52 Reaffirmed, showing predictable growth.
Q3 2025 Revenue $223.1 million Beat analyst consensus, demonstrating execution.

Your next step should be to model the impact of the Paragon acquisition on the 2026 revenue and EBITDA figures, as the market is now trading on the successful integration of that deal.

DCF model

Mirion Technologies, Inc. (MIR) DCF Excel Template

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.